Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: A multicenter cohort study

Biology of Sex Differences

Volumn 6, Issue 1, 2015, Pages

  Bawor, Monica ^a,b,c,d   Dennis, Brittany B ^a,b,c,d   Varenbut, Michael ^e   Daiter, Jeff ^e   Marsh, David C ^e,f   Plater, Carolyn ^e   Worster, Andrew ^a,e   Steiner, Meir ^a,d   Anglin, Rebecca ^a   Pare, Guillaume ^a,c   Desai, Dipika ^c   Thabane, Lehana ^a,g   Samaan, Zainab ^a,c,d  

^a MCMASTER UNIVERSITY   (Canada)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e Canadian Addiction Treatment Centres (CATC)   (Canada)

^f NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^g CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Methadone maintenance treatment; Opioid addiction; Sex differences; Substance use disorders; Women s health

Indexed keywords

EID: 84946429844     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/s13293-015-0038-6     Document Type: Article

References (58)

1. Fischer B, Rehm J, Patra J, Cruz MF. Changes in illicit opioid use across Canada. CMAJ. 2006;175(11):1385.
2. Goodman FD, Glassman P. Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone. Am J Health Syst Pharm. 2005;62:2604–8. United States.
3. Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLoS One. 2013;8:e54496. United States.
4. INCB. Narcotic drugs: estimated world requirements for 2010—statistics for 2008. Vienna, Austria: International Narcotics Control Board; 2010.
5. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009;181:891–6. Canada.
6. Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109(9):1482–8.
7. Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005–2009. Pharmacoepidemiol Drug Saf. 2013;22(4):438–42.
8. Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q. 2011;14(1):22–4.
9. World Drug Report 2014. [http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf]
10. Dhalla IA, Persaud N, Juurlink DN. Facing up to the prescription opioid crisis. BMJ. 2011;343:d5142.
11. Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39(1):1–23.
12. Shield K, Ialomiteanu A, Fischer B, Rehm J. Assessing the prevalence of nonmedical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used. BMC Psychiatry. 2013;13(1):6.
13. Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007;90(1):64–71.
14. Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend. 2009;103(1–2):65–73.
15. Zhong W, Maradit-Kremers H, St Sauver JL, Yawn BP, Ebbert JO, Roger VL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88(7):697–707.
16. Hurley RW, Adams MC. Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008;107:309–17. United States.
17. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–6. United States.
18. Canada H. Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): summary results for 2010. Ottawa, ON: Health Canada; 2011.
19. Methadone maintenance treatment program: Fact sheet.
20. Luce J, Strike C. A cross-Canada scan of methadone maintenance treatment policy developments. Ottawa, ON: Canadian Executive Council on Addictions; 2011.
21. Marsh KL, Simpson DD. Sex differences in opioid addiction careers. Am J Drug Alcohol Abuse. 1986;12(4):309–29.
22. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.
23. Samaan Z, Bawor M, Dennis BB, Plater C, Varenbut M, Daiter J, et al. Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatr Dis Treat. 2014;10:1503–8.
24. Bawor M, Dennis BB, Samaan MC, Plater C, Worster A, Varenbut M, et al. Methadone induces testosterone suppression in patients with opioid addiction. Sci Rep. 2014;4:6189.
25. Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, et al. Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat. 2014;10:2239–47. New Zealand.
26. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93(12):1857–67.
27. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33.
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.
29. Bennett DA. How can I deal with missing data in my study? Aust N Z J Public Health. 2001;25(5):464–9.
30. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9. England.
31. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
32. Savage LJ, Simpson DD. Posttreatment outcomes of sex and ethnic groups treated in methadone maintenance during 1969–1972. J Psychedelic Drugs. 1980;12(1):55–64.
33. Hser YI, Anglin MD, Liu Y. A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. Int J Addict. 1990;25(11a):1295–315.
34. Anglin MD, Hser Y-I, Booth MW. Sex Differences in addict careers. 4. Treatment. Am J Drug Alcohol Abuse. 1987;13(3):253–80.
35. Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst Use Misuse. 1999;34(8):1137–65.
36. Webber MP, Schoenbaum EE, Gourevitch MN, Buono D, Klein RS. A prospective study of HIV disease progression in female and male drug users. Aids. 1999;13(2):257–62.
37. Stenbacka M, Leifman A, Romelsjo A. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods. Drug Alcohol Rev. 2003;22(1):27–34.
38. Mulvaney FD, Brown Jr LS, Alterman AI, Sage RE, Cnaan A, Cacciola J, et al. Methadone-maintenance outcomes for Hispanic and African–American men and women. Drug Alcohol Depend. 1999;54(1):11–8.
39. Cepeda MS, Carr DB. Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg. 2003;97(5):1464–8.
40. Hunt K, Adamson J, Hewitt C, Nazareth I. Do women consult more than men? A review of gender and consultation for back pain and headache. J Health Serv Res Policy. 2011;16(2):108–17.
41. Peles E, Adelson M. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addict Dis. 2006;25(2):39–45.
42. Schiff M, Levit S, Moreno RC. Retention and illicit drug use among methadone patients in Israel: a gender comparison. Addict Behav. 2007;32:2108–19. England.
43. Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Reisinger HS, Peterson JA, et al. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse. 2009;35(1):38–42.
44. Huerta MC, Borgonovi F. Education, alcohol use and abuse among young adults in Britain. Soc Sci Med. 2010;71(1):143–51.
45. Ames GM, Rebhun LA. Women, alcohol and work: Interactions of gender, ethnicity and occupational culture. Soc Sci Med. 1996;43(11):1649–63.
46. BC CfARo. Alcohol and other drug use monitoring: high risk populations. 2013.
47. Kosten TR, Rounsaville BJ, Kleber HD. Ethnic and gender differences among opiate addicts. Int J Addict. 1985;20(8):1143–62.
48. Bawor M, Dennis BB, Bhalerao A, Plater C, Worster A, Varenbut M, et al. Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ Open. 2015;3(3):344–351.
49. Hser YI, Anglin MD, McGlothlin W. Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse. 1987;13(1–2):33–57.
50. Hser YI, Anglin MD, Booth MW. Sex differences in addict careers. 3. Addiction. Am J Drug Alcohol Abuse. 1987;13(3):231–51.
51. Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend. 1997;44(2–3):123–32.
52. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353:221–6. England.
53. Methadone Maintenance Treatment. Program Standards and Clinical Guidelines. [http://www.cpso.on.ca/uploadedFiles/members/MMTGuidelines.pdf]
54. UNODC. Substance abuse treatment and care for women: case studies and lessons learned. New York: United Nations; 2004.
55. SAMHSA. Federal guidelines for opioid treatment programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015.
56. WHO. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland: World Health Organization; 2009.
57. Literature Review—Methadone Maintenance Treatment. [http://www.hcsc.gc.ca/hc-ps/pubs/adp-apd/methadone/index-eng.php]
58. The College of Physicians and Surgeons of Ontario. Methadone maintenance treatment program standards and clinical guidelines. 4th edn. Toronto Canada: The College of Physicians and Surgeons of Ontario; 2011. http://www.cpso.on.ca/uploadedFiles/members/MMT-Guidelines.pdf